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tation, and death were also recorded.
Results: A total of 122 patients underwent an attempted SIA of an iliac
CTO, with success in 101 (83%). Technical failure was due to the inability to
re-enter the lumen in all cases. Mean age of patients was 65 years (range,
42-90 years), with a male/female ratio of 3:2. Clinical profile for this cohort
was remarkable for a high percentage of coronary artery disease (58%),
diabetes (40%), and end-stage renal disease (13%); 32 (32%) of these patients
were considered nonsurgical candidates. Indications for iliac SIA were severe
claudication in 64 (64%) and critical limb ischemia in 37 (36%). Ninety
patients underwent percutaneous SIA, and 11 patients underwent a hybrid
procedure: SIA with an ipsilateral femoral endarterectomy or femoral-to-
distal bypass. Lesion distribution was 69 common iliac arteries and 61
external iliac arteries. In 20 patients, a more distal lumen re-entry was
achieved into the superficial femoral artery (n 16) or the popliteal artery (n
 4). Stents were deployed in 82 patients (81%), with an average of 1.1
stents used (range, 0-3). True lumen re-entry was achieved with an assist
device in 15 patients (15%). Mean ankle-brachial index (ABI) was 0.52
(range, 0.12-0.95) preoperatively and 0.76 (range, 0.36-1.30) postopera-
tively.Mean ABI at last follow-up was 0.80 (range, 0.36-1.20). Claudication
improvement was documented in 46 (72%). At 1 and 2 years, primary
patency was 80% and 69%, respectively, secondary patency was 92% and 86%,
respectively, and limb salvage was 99% and 97%, respectively. The ulcers in
nine of 12 patients healed after SIA. Procedural 30-day mortality rate was 1%
(1 of 101); one patient died from an intraoperative rupture of a proximal
common iliac aneurysm. Survival rate was 93% and 65% at 1 and 4 years,
respectively, reflecting the poor health status of this cohort.
Conclusions: This study demonstrates that SIA of iliac CTO is feasible
and can be performed safely and effectively, even in high-risk patients.
Excellent patency and limb salvage rates can be achieved. In our experience,
the safety and durability of SIA makes it an attractive first-line therapy for
iliac occlusive disease.
Thoracic Endovascular Aortic Repair Broadens Treatment Eligibility
and Decreases Overall Mortality in Traumatic Thoracic Aortic Injury
Michael S. Hong, Robert J. Feezor, W. Anthony Lee, and Peter R. Nelson,
From the University of Florida. Gainesville, Fla
Background:Aortic injury is the second leading cause of death in trauma.
Thoracic endovascular aortic repair (TEVAR) has recently been applied to
traumatic aortic injuries as a minimally invasive alternative to open surgery and
is gaining favor as the preferred treatment option. We sought to determine the
effect of TEVAR on national trends in the management of aortic trauma.
Methods: The Nationwide Inpatient Sample (NIS) was queried from the
years 2001 to 2007, and patients diagnosed with injury to the thoracic aorta
were selected using code 901.0 of the International Classification of Diseases
(9th ed). Patients were evaluated based on open surgical repair, TEVAR, or
nonoperative management, before and after widespread adoption of TEVAR
for aortic trauma (2001 to 2005 and 2006 to 2007; Fig). Analyses with 2 and
t tests were performed to determine trends in the use of open surgery, use of
TEVAR, inpatient death, major complications, and length of stay.
Results: The NIS documented an average of 241 inpatient admissions
with a diagnosis of thoracic aortic trauma per year, corresponding to an
estimated 1180 yearly admissions in the United States. A comparison of the
time periods 2001 to 2005 and 2006 to 2007 showed a significant increase in
TEVAR (P .001) with a concomitant decrease in open repair (P .001) in
2006 to 2007. The overall number of interventions significantly increased (P
● Rates of open surgical repair, thoracic endovascular aneurysm
repair (TEVAR), or nonoperative management, before and after
widespread adoption of TEVAR for aortic trauma.001). The overall mortality rate significantly decreased (24.8% vs 18.7%, P 
.006), corresponding to a trend toward improved survival in the nonoperative
group (27.8% vs 25.0%, P .053). There was no improvement in open repair
mortality rates between the two time periods. The TEVAR group had a
significantly higher percentage of patients with intra-abdominal injuries (85% vs
70%,P .002), and hemothorax (48% vs 36%,P .038) than the open surgery
group; however, there were no differences in the number of closed head injuries
or major orthopedic fractures. The open surgery group had higher rates of
postoperative respiratory failure (61%vs 50%,P .047), but nodifferenceswere
seen in paraplegia or renal failure. Overall in-hospital mortality was 22.9%:
26.3% among the nonoperative group, 12.2%with open repair, and 10.4%with
TEVAR. The difference in mortality between open repair and TEVAR was not
significant. Length of stay was 15 days in the TEVAR group compared 22 days
with open repair (P .001).
Conclusions: Among patients with aortic trauma, the use of TEVAR has
decreased the rate of open aortic repair and increased the overall number of
patients receiving intervention. Since the wider adoption of TEVAR in 2006,
fewer patients are managed nonoperatively, and overall survival has improved.
There was no difference in mortality between TEVAR and open repair in our
study, which may reflect more aggressive treatment in the TEVAR group of
those who previously would not have been offered intervention due to injury
severity. Evidence suggests that TEVAR has made a significant impact in the
management of this trauma population nationally, although more studies are
indicated to further clarify its role in traumatic aortic disruption.
Does the Current Reimbursement System Make Sense? A Real-World
Analysis of Payment Per Unit Time in a Maryland Vascular Practice
John D. Martin, Patricia B. Warble, Jerry E. Mapes, Linda L. Weiss, Toni B.
Schiller, Kimberly A. England, Louise A. Hanson, Jon A. Altschuler, Jon A.
Hupp, and Stephen F. Stanziale, From the Anne Arundel Medical Center.
Annapolis, Md
Background: In 1992, the Centers for Medicare and Medicaid Services
instituted the Resource Based Relative Value Scale (RBRVS) system to deter-
mine physician reimbursement, incorporating three components of physician
services: physician work, practice expense, and liability insurance. The relative
value units (RVU) are assigned to eachCurrent Procedural Terminology (CPT)
code and are intended to reflect the time and intensity of work. This RVU is the
core value that determines the “fair” reimbursement for physician work. Does
this system accurately balance the true time it takes for each procedure? The
purpose of this study was to determine how well this system distributes pay-
ments for hospital-based procedures during a 12-month period.
Methods: From July 1, 2008, to June 30, 2009, procedural times for
all vascular interventions (time into room until time out of room) were
recorded. Additionally recorded were 15 minutes for administrative time on
the day of the procedure, each hospital day, and all office visits within the
global period (the total care time). The actual physician’s total fee collected
for each of these procedures was divided by the total care time to determine
the payment per unit time. We did not isolate unbundled codes, but rather
reported the total reimbursement for the entire procedure to more accu-
rately reflect the typical vascular experience.
Results: Data were collected on all 1103 procedures performed during this
period. The analysis excluded 37 patients (35 no payments received, 2 incomplete
times recorded). Carrier distribution was 75%Medicare and 25% private.
Table. Reimbursement per unit time is reflected in the
following chart for each of the major procedures:
Procedure Number
OR time
(hrs)
Post-op
days
Consult
time (hrs)
Reimbursement
Total$ $/h
Aortic bypass 15 65.9 52 22.75 31,809 359
Aortic endograft 25 66.9 36 27.25 55,807 593
Abdominal endovascular 39 62.4 0 9.75 44,200 612
Carotid endarterectomy 118 242.9 150 116.00 137,559 383
Carotid stent 20 27.4 20 13.25 26,419 650
Cerebral arteriography 7 8.2 0 1.75 4867 487
Bypass graft revision
Open 6 14.8 15 7.25 8439 382
Endo 5 6.1 0 1.25 4523 617
LE bypass 45 166.5 145 74.00 70,211 292
L. extremity endarterectomy 23 54.4 34 23.75 38,452 492
L. extremity endovascular 179 270.7 0 44.75 192,139 609
L. extremity thrombectomy 13 32.1 57 23.00 20,166 366
Dialysis graft revision
Open 46 73.5 56 39.75 32,019 283
Endo 119 125.5 4 35.00 85,725 534
Dialysis access 76 127.7 15 56.25 49,328 268
L. extremity arteriography 106 117.4 0 26.50 52,310 364
Fistulogram 12 9,7 0 3.00 3261 245
Caval filter insert/remove 22 17.3 39 15.50 19,891 606
L. extremity venous 30 34.8 0 15.25 19,498 389
L. extremity amputation 47 65.5 244 90.25 34,686 223
Visceral endovascular 32 43.3 0 8.00 35,020 682
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subjective surveys rather than by prospectively collecting accurate workload
data. This unique study demonstrates a real-world experience of reimburse-
ment per unit time and raises questions about the validity of the RBRVS
process. The disparity between payments for open and endovascular repair of
similar conditions, such as aortic aneurysm and carotid stenosis, are typical of
this inequality. These data do not reflect the intangible time of operative
planning, administrative matters, or overhead, and these are factors that
must be considered when interpreting this information. Regardless, this
study suggests that capturing detailed financial data is possible and is a more
accurate source for future discussions on reimbursement.
Cerebral Microembolization: Open vs Percutaneous Carotid
Revascularization
Naren Gupta, Thomas F. Dodson, Matthew A. Corriere, Elliot L. Chaikof,
James G. Reeves, Ravi K. Veeraswamy, and Karthikeshwar Kasirajan, From
Emory University School of Medicine. Atlanta, Ga
Background: A cumulative burden of data suggest that microemboli-
zation to the brain may result in long-term cognitive dysfunction despite the
absence of immediate overt cerebrovascular events. We reviewed a series of
patients treated electively with carotid endarterectomy (CEA), carotid stent-
ing with filter (CAS), and carotid stenting with flow reversal (FRS) moni-
tored continuously with transcranial Doppler (TCD) imaging during the
procedure to detect microembolization rates.
Methods: TCD insonation of the M1 segment of the middle cerebral
artery was conducted during 39 procedures (14 CEA, 18 CAS, and 7 FRS)
in 38 patients seen at an academic center. One patient had staged bilateral
CEAs. TCD detects intraprocedural microemboli as high-intensity transient
signals (HITS). Cerebral blood flow dynamics and HITS were monitored
ipsilaterally for CEA patients and bilaterally for CAS and FRS patients.
Ipsilateral HITS were divided into three phases: preprotection phase (until
the internal carotid artery was cross-clamped or shunted, filter deployed, or
flow reversal established), protection phase (until clamp/shunt removed,
filter removed, or antegrade flow re-established), and postprotection phase
(after clamp/shunt removed, filter removed, or antegrade flow re-estab-
lished). Descriptive statistics are reported as mean  standard error for
continuous variables and number (%) for categoric variables. Differences in
ipsilateral emboli counts based on cerebral protection strategy were assessed
using nonparametric methods (Kruskal-Wallis test).
Results: TCD insonation and procedural success was obtained in 29
procedures (13 CEA, 11 CAS, and 5 FRS). Groups did not differ in baseline
demographics. Total ipsilateral HITs were significantly different across all
three groups (P .001) as well as by separate two-group comparisons: CEA
vsCAS (P .001),CEAvs FRS (P .002), andFRS vsCAS (P .027;Table).
Patients undergoing CEA had significantly fewer HITS than FRS or CAS for
all three phases (preprotection, protection, postprotection, P  .001).
Conclusions: CEA has the least microembolic potential and should
remain the gold standard for carotid revascularization. Microembolization is
decreased during carotid stenting with flow reversal compared with stenting
using distal protection. Most of this benefit is due to a decrease during the
protection phase of the procedure. These findings support flow reversal as a
more effective manner of microembolic protection than distal filter protec-
tion in patients requiring percutaneous carotid revascularization. The clini-
cal implications of these data need further evaluation by postprocedural
long-term cognitive assessment and diffusion-weighted magnetic resonance
imaging studies.
Atherosclerotic Plaque Composition and Cerebral Embolization after
Carotid Stenting
Carlos Timaran, Eric B. Rosero, Andres E. Martinez, Adriana Ilarraza, J.
Gregory Modrall, and G. Patrick Clagett, From the University of Texas
Southwest Medical Center. Dallas, Tex
Background: Previous studies have investigated the predictive value of
clinical and morphologic parameters for distal embolization during carotid
interventions. The composition of the atherosclerotic plaque using virtual
histology intravascular ultrasound (VH IVUS) imaging at the interventionsite has not been evaluated as a marker for cerebral embolization. The
purpose of this study was to assess the relationship between atherosclerotic
plaque composition determined with VH IVUS and the occurrence of
cerebral embolization after carotid angioplasty and stenting (CAS).
Methods: During a 10-month period, 24 patients undergoing CAS
procedures using a filter device for embolic protection (Accunet Filter,
Abbott Vascular, Santa Clara, Calif) were prospectively evaluated. All pa-
tients underwent VH IVUS imaging before the intervention, transcranial
Doppler (TCD) monitoring during CAS, and preprocedural and 24-hour
postprocedural diffusion-weighted magnetic resonance imaging (DW-
MRI). VH-IVUS characterized plaque components as fibrotic, fibrofatty,
dense calcium, and necrotic core. The frequency of Doppler-detected mi-
croembolic signals (MES) during CAS and the incidence and location of
acute, postprocedural embolic lesions detected with DW-MRI was assessed
to determine cerebral embolization. Univariate and linear regression analy-
ses were used to assess the association between plaque composition and the
frequency of cerebral embolization.
Results: No periprocedural transient ischemic attacks, strokes, or
deaths occurred at 30 days. DW-MRI demonstrated new acute cerebral
emboli in 14 patients (58%). All revealed ipsilateral lesions, and eight (32%)
had also contralateral lesions. For the entire study group, the median
number of DW-MRI lesions was two (range, 0-173) and the TCD MES
counts were 222 (interquartile range, 152-322) .Of the plaque components,
DW-MRI determined that only dense calcium was significantly associated
with cerebral embolization. The proportion of dense calcium was signifi-
cantly larger in patients with cerebral embolization (5.7% 2.2% vs 1.2%
0.3%, P .04). Findings on postprocedural DW-MRI did not correlate with
the proportion of fibrotic, fibrofatty, and necrotic core. Degree of cerebral
embolization during CASmeasured with TCD did not correlate with plaque
composition.
Conclusions: Plaque composition, as determined by VH IVUS, cor-
relates with the degree of cerebral embolization after CAS but not during the
intervention. Specifically, the proportion of dense calcium is strongly asso-
ciated with the occurrence of cerebral embolization after CAS. Of note, the
proportion of necrotic core, which has traditionally defined the presence of
a vulnerable or unstable plaque, does not correlate with the degree of distal
embolization after CAS when a filter device for embolic protection is used.
Optimal management and strategies to prevent distal embolization after
CAS of lesions with significant dense calcium warrant further investigation.
Vascular Surgical Antibiotic Prophylactic Study (VSAPS)
Patrick A. Stone, and Ali F. AbuRahma, From West Virginia University.
Charleston, WV
Background: Methicillin-resistant Staphylococcus aureus (MRSA) is
becoming increasingly prevalent in postoperative wound infections, espe-
cially vascular surgery. A major concern is the routine use of cefazolin as
antimicrobial prophylaxis in open peripheral vascular procedures. This reg-
imen may not provide adequate coverage of resistant organisms, such as
MRSA. Therefore, this study was designed to evaluate the efficacy of
MRSA-specific coverage vs traditional routine surgical prophylaxis.
Objective:Themain goal of this prospective, randomized study, which
was performed at a single institution, was to delineate if MRSA-specific
prophylaxis in elective vascular surgery is efficacious.
Methods: Upon approval by the Investigational Review Board, low-
risk patients undergoing elective vascular procedures were enrolled from
August 2007 to June 2009. Participants were randomized into three sepa-
rate arms. They received cefazolin, cefazolin plus vancomycin, or cefazolin
plus daptomycin as antimicrobial prophylaxis before surgery. Patients were
blinded to their randomized group.
Results: A total of 203 patients were enrolled over 22 months. After
excluding 10 ineligible patients, 193 were randomized to one of three
groups: 75 in the cefazolin group, 69 in the cefazolin  vancomycin group
and 59 in the cefazolin daptomycin group. Mean age was 66 years (range,
26-89 years), and patient comorbidities were similar across all groups.
Presence of postoperative infection was categorized by a Szulgai I, II, or III
designation. Infection occurred in eight patients (11%) in the cefazolin
group, eight (12.5%) in the cefazolin plus vancomycin group, and two
(3.6%) in the cefazolin plus daptomycin group. Pathogens isolated from
wound cultures included Proteus mirabilis, MRSA, Klebsiella pneumonia,
Enterobacter cloacae, Pseudomonas, non-MRSA spp, Fermenter, and non-
Fermenter spp. MRSA infections occurred in one patient (1.4%) in the
cefazolin group, four (6.3%) in the cefazolin plus vancomycin group, and in
no patients (0%) in the cefazolin plus daptomycin group.
Conclusions: In this study population of low-risk patients undergoing
elective vascular procedures, there was a trend toward fewer infectious
complications in the cefazolin plus daptomycin group, although it did not
reach statistical significance. Further investigation is necessary to delineate
the efficacy of MRSA prophylaxis in other groups, including high-risk
individuals.
